
Back
Anticoagulant and Antiplatelet Therapies
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Heidi Overton's FDA Nomination Could Mean for Pharmacy
2
August 2026 in Oncology: FDA Approvals and Phase 3 Data Reshape Treatment Across Tumor Types
3
New Lipid Drugs and What Pharmacists Need to Know
4
FDA Approves Ustekinumab Injection for Pediatric Ulcerative Colitis, Expanding IBD Options for Children
5





